Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1000

1.

Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.

Yeo CJ, Abrams RA, Grochow LB, Sohn TA, Ord SE, Hruban RH, Zahurak ML, Dooley WC, Coleman J, Sauter PK, Pitt HA, Lillemoe KD, Cameron JL.

Ann Surg. 1997 May;225(5):621-33; discussion 633-6.

2.

Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.

Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M; Study Group for Therapies of Rectal Malignancies (STORM)..

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39.

PMID:
16414206
3.

Clinical overview: adjuvant therapy of gastrointestinal cancer.

Macdonald JS.

Cancer Chemother Pharmacol. 2004 Sep;54 Suppl 1:S4-11. Review.

PMID:
15309508
4.

Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome.

Pucciarelli S, Toppan P, Friso ML, Russo V, Pasetto L, Urso E, Marino F, Ambrosi A, Lise M.

Dis Colon Rectum. 2004 Nov;47(11):1798-807.

PMID:
15622571
5.

The role of surgery and postoperative chemoradiation therapy in patients with lymph node positive esophageal carcinoma.

Bédard EL, Inculet RI, Malthaner RA, Brecevic E, Vincent M, Dar R.

Cancer. 2001 Jun 15;91(12):2423-30.

PMID:
11413534
6.
7.

Chemoradiotherapy in the treatment of regional pancreatic carcinoma: a phase II study.

Al-Sukhun S, Zalupski MM, Ben-Josef E, Vaitkevicius VK, Philip PA, Soulen R, Weaver D, Adsay V, Heilbrun LK, Levin K, Forman JD, Shields AF.

Am J Clin Oncol. 2003 Dec;26(6):543-9.

PMID:
14663369
8.

Improved survival with adjuvant external-beam radiation therapy in lymph node-negative pancreatic cancer: a United States population-based assessment.

Artinyan A, Hellan M, Mojica-Manosa P, Chen YJ, Pezner R, Ellenhorn JD, Kim J.

Cancer. 2008 Jan 1;112(1):34-42.

9.

En bloc resection for locally advanced cancer of the pancreas: is it worthwhile?

Sasson AR, Hoffman JP, Ross EA, Kagan SA, Pingpank JF, Eisenberg BL.

J Gastrointest Surg. 2002 Mar-Apr;6(2):147-57; discussion 157-8.

PMID:
11992799
10.

D1 versus D2 pancreatoduodenectomy in surgical therapy of pancreatic head cancer.

Gazzaniga GM, Cappato S, Papadia F, Mori L, Filauro M.

Hepatogastroenterology. 2001 Sep-Oct;48(41):1471-8.

PMID:
11677990
11.

Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005).

Corsini MM, Miller RC, Haddock MG, Donohue JH, Farnell MB, Nagorney DM, Jatoi A, McWilliams RR, Kim GP, Bhatia S, Iott MJ, Gunderson LL.

J Clin Oncol. 2008 Jul 20;26(21):3511-6. doi: 10.1200/JCO.2007.15.8782.

PMID:
18640932
12.

Adjuvant chemoradiation for patients with adenocarcinoma of the pancreas: an expirence of single institute.

Yazar A, Ustüner Z, Sakar B, Kaytan Sağlam E, Camlica H, Aykan F.

Med Oncol. 2007;24(4):384-7.

PMID:
17917086
13.

Long term survival after pancreatic resection for pancreatic adenocarcinoma.

Ahmad NA, Lewis JD, Ginsberg GG, Haller DG, Morris JB, Williams NN, Rosato EF, Kochman ML.

Am J Gastroenterol. 2001 Sep;96(9):2609-15.

PMID:
11569683
14.

Adjuvant concurrent chemoradiation for node-positive adenocarcinoma of the duodenum.

Swartz MJ, Hughes MA, Frassica DA, Herman J, Yeo CJ, Riall TS, Lillemoe KD, Cameron JL, Donehower RC, Laheru DA, Hruban RH, Abrams RA.

Arch Surg. 2007 Mar;142(3):285-8.

PMID:
17372054
15.

Adjuvant therapy in pancreatic cancer: a critical appraisal.

Oettle H, Neuhaus P.

Drugs. 2007;67(16):2293-310. Review.

PMID:
17983252
17.

Predictors of recurrence after local excision and postoperative chemoradiation therapy of adenocarcinoma of the rectum.

Bouvet M, Milas M, Giacco GG, Cleary KR, Janjan NA, Skibber JM.

Ann Surg Oncol. 1999 Jan-Feb;6(1):26-32.

PMID:
10030412
18.

Chemoradiation followed by chemotherapy before resection for borderline pancreatic adenocarcinoma.

Brown KM, Siripurapu V, Davidson M, Cohen SJ, Konski A, Watson JC, Li T, Ciocca V, Cooper H, Hoffman JP.

Am J Surg. 2008 Mar;195(3):318-21. doi: 10.1016/j.amjsurg.2007.12.017.

PMID:
18308038
19.

Pancreatic resections after chemoradiotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival.

Massucco P, Capussotti L, Magnino A, Sperti E, Gatti M, Muratore A, Sgotto E, Gabriele P, Aglietta M.

Ann Surg Oncol. 2006 Sep;13(9):1201-8.

PMID:
16955382
20.

[Radiotherapeutic strategies in the multimodal therapy of resectable and nonresectable pancreatic carcinoma].

Wiegel T, Runkel N, Frommhold H, Rübe C, Hinkelbein W.

Strahlenther Onkol. 2000 Jul;176(7):299-306. Review. German.

PMID:
10962995
Items per page

Supplemental Content

Support Center